-
Product Insights
Septic Shock – Drugs In Development, 2023
Global Markets Direct’s, ‘Septic Shock - Drugs In Development, 2023’, provides an overview of the Septic Shock pipeline landscape. The report provides comprehensive information on the therapeutics under development for Septic Shock, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewSepsis – Drugs In Development, 2024
Empower your strategies with our Sepsis – Drugs In Development, 2024 report and make more profitable business decisions. Sepsis is an illness in which the body has a severe response to bacteria or other germs. Sepsis occurs when chemicals released into the bloodstream to fight the infection trigger inflammation throughout the body. This response may be called systemic inflammatory response syndrome (SIRS). Symptoms of sepsis include chills, shaking, difficulty breathing, decrease in platelet count, abnormal heart pumping function, and abdominal pain....
-
Product Insights
NewMycobacterium tuberculosis Infections – Drugs In Development, 2024
Empower your strategies with our Mycobacterium tuberculosis Infections – Drugs In Development, 2024 report and make more profitable business decisions. The group of infections caused by Mycobacterium tuberculosis (M. tuberculosis) are referred to as Mycobacterium tuberculosis infections, which primarily affect the lungs but can also impact other parts of the body. The symptoms include persistent cough, fever, weight loss, and night sweats. Treatment typically involves a combination of antibiotics taken over several months. M. tuberculosis infections remain a significant global health...
-
Product Insights
NewTuberculosis – Drugs In Development, 2024
Empower your strategies with our Tuberculosis – Drugs In Development, 2024 report and make more profitable business decisions. Tuberculosis, commonly known as TB, is a bacterial infection that can spread through the lymph nodes and bloodstream to any organ in body. It is most often found in the lungs. The symptoms of tuberculosis range from no symptoms (latent tuberculosis) to symptoms of active disease. Symptoms include overall sensation of feeling unwell; cough, possibly with bloody mucus; fatigue; shortness of breath; weight...
-
Product Insights
Interstitial Lung Fibrosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Interstitial Lung Fibrosis - Drugs In Development, 2023’, provides an overview of the Interstitial Lung Fibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Interstitial Lung Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Mycobacterium Tuberculosis Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Traditional diagnosis of Mycobacterial infections depends upon smear positivity in sputum samples, culture, and chest radiography. For rapid diagnosis, polymerase chain reaction (PCR), immune-based assays such as enzyme-linked immunosorbent assay (ELISA), skin patch test, and rapid culture systems are performed. The Mycobacterium tuberculosis tests pipeline market research report provides comprehensive information about the Mycobacterium tuberculosis tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Sector Analysis
United Kingdom Diagnostic Imaging Market Outlook to 2025 – Angio Suites, Bone Densitometers, C-Arms, Computed Tomography (CT) Systems and Others
GlobalData’s “United Kingdom Diagnostic Imaging Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United Kingdom Diagnostic Imaging market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Angio Suites, Bone Densitometers, C-Arms, Computed Tomography (CT) Systems, Contrast Media Injectors, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems. The United Kingdom Diagnostic Imaging Market report provides key information and data on: • Annualized market...
-
Sector Analysis
United Kingdom In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.
GlobalData’s “United Kingdom In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United Kingdom In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United Kingdom In Vitro Diagnostics Market report provides key information and data on: • Annualized market...